• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Novo Nordisk A/S (NVO)

    -NYSE
    44.56 Down 1.36(2.96%) Jan 30, 4:05PM EST
    Add to Portfolio
    Prev Close:45.92
    Open:45.20
    Bid:44.50 x 100
    Ask:57.01 x 200
    1y Target Est:50.76
    Beta:0.99
    Next Earnings Date:N/A
    Day's Range:44.53 - 45.33
    52wk Range:39.24 - 49.11
    Volume:1,091,485
    Avg Vol (3m):1,368,870
    Market Cap:115.92B
    P/E (ttm):29.93
    EPS (ttm):1.49
    Div & Yield:0.61 (1.30%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVODown 2.96%115.92B
    LLYDown 0.15%77.97B
    PFEDown 1.82%196.90B
    SNYDown 1.94%120.95B

    Key Statistics

    Forward P/E (1 yr):24.09
    P/S (ttm):8.83
    Ex-Dividend Date:21-Mar-14

    Analysts

    Annual EPS Est (Dec-14) :1.62
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.97

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback